Analysis of a model for the pathogenesis of AIDS.
暂无分享,去创建一个
[1] B. Rocha,et al. Lymphocyte lifespans: homeostasis, selection and competition. , 1993, Immunology today.
[2] M. Somasundaran,et al. Unexpectedly high levels of HIV-1 RNA and protein synthesis in a cytocidal infection. , 1988, Science.
[3] D. Richman,et al. A cross-sectional comparison of persons with syncytium- and non-syncytium-inducing human immunodeficiency virus. , 1993, The Journal of infectious diseases.
[4] A. Fauci,et al. The immunopathogenesis of human immunodeficiency virus infection. , 1993, The New England journal of medicine.
[5] A. McLean,et al. Lifespan of human lymphocyte subsets defined by CD45 isoforms , 1992, Nature.
[6] J. Phair,et al. A1, Cw7, B8, DR3 HLA antigen combination associated with rapid decline of T-helper lymphocytes in HIV-1 infection A report from the Multicenter AIDS Cohort Study , 1990, The Lancet.
[7] Andrew N. Phillips,et al. Reduction of HIV Concentration During Acute Infection: Independence from a Specific Immune Response , 1996, Science.
[8] R. Coutinho,et al. HIV‐1 biological phenotype in long‐term infected individuals evaluated with an MT‐2 cocultivation assay , 1992, AIDS.
[9] J. Groopman,et al. Characterization of Serum Netralization Response to the Human Immunodeficiency Virus (HIV) , 1987 .
[10] R. V. van Lier,et al. AIDS pathogenesis: a dynamic interaction between HIV and the immune system. , 1990, Immunology today.
[11] Robin A. Weiss,et al. How does HIV cause AIDS , 1993 .
[12] F. Walshe. The structure of medicine. , 1948, Lancet.
[13] Martin A. Nowak,et al. Viral dynamics in human immunodeficiency virus type 1 infection , 1995, Nature.
[14] D. Ho,et al. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome , 1994, Journal of virology.
[15] S. Vermund,et al. Long-term survivors of HIV-1 infection: Definitions and research challenges , 1994 .
[16] D Schenzle,et al. A model for AIDS pathogenesis. , 1994, Statistics in medicine.
[17] John W. Ward,et al. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. , 1993, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.
[18] I. Keet,et al. Prognostic Value of HIV-1 Syncytium-Inducing Phenotype for Rate of CD4+ Cell Depletion and Progression to AIDS , 1993, Annals of Internal Medicine.
[19] J. Albert,et al. REPLICATIVE CAPACITY OF HUMAN IMMUNODEFICIENCY VIRUS FROM PATIENTS WITH VARYING SEVERITY OF HIV INFECTION , 1986, The Lancet.
[20] J. Spouge,et al. Quantifying the infectivity of human immunodeficiency virus. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[21] R. Kaslow,et al. The role of the major histocompatibility complex in human immunodeficiency virus infection--ever more complex? , 1994, Journal of Infectious Diseases.
[22] J. Phair. Keynote address: variations in the natural history of HIV infection. , 1994, AIDS research and human retroviruses.
[23] A. Perelson,et al. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection , 1995, Nature.
[24] A. Perelson,et al. HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation Time , 1996, Science.
[25] D. Ho,et al. Human immunodeficiency virus type 1 variants with increased replicative capacity develop during the asymptomatic stage before disease progression , 1994, Journal of virology.
[26] F. de Wolf,et al. Biphasic rate of CD4+ cell count decline during progression to AIDS correlates with HIV‐1 phenotype , 1992, AIDS.
[27] J. Goedert,et al. HLA phenotype is a factor in determining rate of disease progression and outcome in HIV-1-infected individuals. , 1992, AIDS Research and Human Retroviruses.
[28] A. McLean,et al. In vivo estimates of division and death rates of human T lymphocytes. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[29] B. Walker,et al. Strong cytotoxic T cell and weak neutralizing antibody responses in a subset of persons with stable nonprogressing HIV type 1 infection. , 1996, AIDS research and human retroviruses.